NPT-0025 / Nexel - LARVOL DELTA

NEXEL (BIO 2022) - "Our protein/Peptide therapy pipelines, NP-011 and NPT-0025, were designed by remodeling a protein found in embryonic stem cell secretomes. NEXEL is a specialist in the differentiation of human iPSC, having successfully developed several off-the-shelf products such as cardiomyocytes, hepatocytes, and neurons. hiPSC-derived cells are proving to be an excellent in vitro model to potentially revolutionize preclinical drug toxicity testing, as evidenced by upcoming ICH guideline changes(S7B) with CiPA."

Fibrosis • Hepatology • Immunology • Non-alcoholic Steatohepatitis